---
schema_version: "secwatch.filing_event.v1"
accession: "0001999480-26-000024"
form_type: "8-K"
ticker: "ANRO"
cik: "0001999480"
company_name: "Alto Neuroscience, Inc."
filed_at: "2026-08-27T21:18:31+00:00"
generated_at: "2026-08-27T21:20:08.166152+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Alto Neuroscience promotes CFO Nicholas Smith to President and CFO; Etkin stays CEO

## Summary
- Effective Aug 26, 2026, Nicholas C. Smith promoted from CFO/CBO to President and CFO.
- Amit Etkin remains CEO but no longer President; stays principal executive officer.
- Smith receives $6M retention payment: $3M within 10 days, $3M at 12-month anniversary.
- Retention payment requires 2-year employment; repayment if resignation or termination for cause.
- Agreement filed as Exhibit 10.1; no family relationships or Item 404(a) transactions.

## SEC filing metadata
- accession: 0001999480-26-000024
- form_type: 8-K
- ticker: ANRO
- cik: 0001999480
- company_name: Alto Neuroscience, Inc.
- filed_at: 2026-08-27T21:18:31+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1999480/000199948026000024/0001999480-26-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1999480/000199948026000024/alto-20260826.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001999480-26-000024
- JSON: https://secwatch.observer/filing/0001999480-26-000024.json
- Plain text: https://secwatch.observer/filing/0001999480-26-000024.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.